JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

JNJ

225.57

+0.63%↑

UNH

363.82

-1.87%↓

TMO

466.62

+0.92%↑

ISRG

451.55

-0.21%↓

ABT

87.15

-0.47%↓

Inicio・Lista de Acciones・Danaher Corp

Search

Danaher Corp

Cerrado

SectorSanidad

174.62 0.32

Resumen

Variación precio

24h

Actual

Mínimo

173.22

Máximo

176.42

Métricas clave
By Trading Economics
Ingresos	-168M 1B
Ventas	-887M 6B
P/B Media del Sector	34.936 67.147
BPA	2.06
Rentabilidad por dividendo	0.77
Margen de beneficios	17.291
Empleados	58,000
EBITDA	-514M 1.5B

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 Meses	+34.3% upside

Dividendos
By Dow Jones
Rentabilidad por dividendo Media del Sector	0.77% 2.36%
Próximas Ganancias	21 jul 2026
Fecha Próximo Dividendo	24 jul 2026
Próxima Fecha de Ex Dividendo	26 jun 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-11B 128B
Apertura anterior	174.3
Cierre anterior	174.62

Noticias sobre sentimiento de mercado

By Acuity

23%

77%

76 / 347 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

189.8851 / 196.5 Soporte y Resistencia

Danaher Corp Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

21 abr 2026, 11:36 UTC

Ganancias

Danaher Lifts Full-Year Forecast on Biotech, Life Sciences Gains -- Update

21 abr 2026, 11:00 UTC

Ganancias

Danaher Raises Adjusted Earnings Guidance, 1Q Revenue, Profit Rise

21 abr 2026, 10:06 UTC

Ganancias

Danaher 1Q Adjsuted Core Revenue Rose 0.5% >DHR

21 abr 2026, 10:05 UTC

Ganancias

Danaher Sees 2Q Adjsuted Core Revenue Up Low-Single Digits >DHR

21 abr 2026, 10:05 UTC

Ganancias

Danaher Still Sees 2026 Adjsuted Core Revenue Up 3%-6% >DHR

21 abr 2026, 10:05 UTC

Ganancias

Danaher Had Seen 2026 Adjusted EPS $8.35-$8.50 >DHR

21 abr 2026, 10:04 UTC

Ganancias

Danaher Raises 2026 View To Adj EPS $8.35-Adj EPS $8.55 >DHR

21 abr 2026, 10:04 UTC

Ganancias

Danaher 1Q Operating Cash Flow $1.3B, Adjusted Free Cash Flow $1.1B >DHR

21 abr 2026, 10:00 UTC

Ganancias

Danaher 1Q Cont Ops EPS $1.45 >DHR

21 abr 2026, 10:00 UTC

Ganancias

Danaher 1Q Adj EPS $2.06 >DHR

21 abr 2026, 10:00 UTC

Ganancias

Danaher 1Q Sales $5.95B >DHR

21 abr 2026, 10:00 UTC

Ganancias

Danaher 1Q EPS $1.45 >DHR

21 abr 2026, 10:00 UTC

Ganancias

Danaher 1Q Net $1.03B >DHR

17 abr 2026, 19:15 UTC

Charlas de Mercado

Danaher Seen Rebounding in 2H After Tools-Sector Weakness -- Market Talk

17 abr 2026, 19:07 UTC

Charlas de Mercado

Danaher Faces Tough Comparative but Long‑Term Story Intact -- Market Talk

17 feb 2026, 20:06 UTC

Adquisiciones, fusiones, absorciones

This Medical-Devices Stock Is Soaring. Danaher Is Buying the Company. -- Barrons.com

17 feb 2026, 15:14 UTC

Adquisiciones, fusiones, absorciones

Masimo Stock on Pace for Record Gains After Danaher Strikes Deal -- WSJ

17 feb 2026, 14:39 UTC

Adquisiciones, fusiones, absorciones

This Medical-Devices Stock Is Soaring. It's Being Bought by Danaher. -- Barrons.com

17 feb 2026, 13:30 UTC

Adquisiciones, fusiones, absorciones

This Medical-Devices Stock Is Soaring. It's Being Bought by Danaher. -- Barrons.com

17 feb 2026, 13:15 UTC

Adquisiciones, fusiones, absorciones

Danaher Strikes $10 Billion Deal for Masimo -- Update

17 feb 2026, 13:03 UTC

Adquisiciones, fusiones, absorciones

Danaher To Fund Masimo Acquisition With Cash on Hand, Debt Financing >DHR

17 feb 2026, 13:03 UTC

Adquisiciones, fusiones, absorciones

Danaher Sees More Than $125M Annual Cost Synergies, More Than $50M Annual Revenue Synergies by Fifth Full Year >DHR MASI

17 feb 2026, 13:02 UTC

Adquisiciones, fusiones, absorciones

Danaher Sees Masimo Deal Adding About 70c to Adjusted EPS in Fifth Full Year >DHR MASI

17 feb 2026, 13:02 UTC

Adquisiciones, fusiones, absorciones

Danaher Sees Masimo Deal Adding 15c-20c to Adjusted EPS in First Full Year >DHR MASI

17 feb 2026, 13:02 UTC

Adquisiciones, fusiones, absorciones

Masimo To Be Acquired By Danaher For $180.00 Per Share >MASI DHR

17 feb 2026, 13:01 UTC

Adquisiciones, fusiones, absorciones

Danaher to Buy Masimo for Total Enterprise Value of About $9.9 Billion >DHR MASI

17 feb 2026, 13:00 UTC

Adquisiciones, fusiones, absorciones

Danaher to Buy Masimo for $180/Share >DHR MASI

17 feb 2026, 13:00 UTC

Adquisiciones, fusiones, absorciones

Danaher To Acquire Masimo Corporation >DHR MASI

17 feb 2026, 11:09 UTC

Adquisiciones, fusiones, absorciones

Danaher Strikes $10 Billion Deal for Masimo -- WSJ

17 feb 2026, 11:09 UTC

Adquisiciones, fusiones, absorciones

Danaher Acquisition of Masimo Set to Be Announced Tuesday, Sources Say -- WSJ

Comparación entre iguales

Cambio de precio

Danaher Corp previsión

Precio Objetivo

By TipRanks

34.3% repunte

Estimación a 12 Meses

Media 233.74 USD 34.3%

Máximo 270 USD

Mínimo 184.04 USD

De acuerdo con 16 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Danaher Corp Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

16 ratings

14

Comprar

2

Mantener

0

Vender

De acuerdo con 16 analistas que ofrecen calificaciones bursátiles a para Danaher Corp Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

189.8851 / 196.5Soporte y Resistencia

Recent bullish events outweigh bearish events.

There is one bullish event.

The bullish and bearish events are balanced.

Sentimiento

By Acuity

76 / 347 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Danaher Corp

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company has a research collaboration with Stanford University's Department of Bioengineering for cancer drug development. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.

Otras acciones del sector

JNJ

Johnson and Johnson

225.57

UNH

UnitedHealth Group Inc

363.82

TMO

Thermo Fisher Scientific Inc

466.62

ISRG

Intuitive Surgical Inc

451.55

ABT

Abbott Laboratories

87.15

Live chat